Skip to content

Sexual Health Communication Skills Training Intervention for Patients With Prostate Cancer

Pilot Testing a Sexual Health Communication Skills Training Intervention for Patients With Prostate Cancer

Status
Not yet recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07655557
Enrollment
100
Registered
2026-06-18
Start date
2026-08-01
Completion date
2028-10-31
Last updated
2026-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Prostate Cancer

Keywords

Prostate Cancer, Sexual Health, Health Communication

Brief summary

This is a pilot randomized controlled trial of a sexual health communication skills training multimedia intervention (Starting the Conversation \[STC\] adapted for patients with prostate cancer \[PCa\]) to improve patients' ability to communicate with providers about their sexual health concerns during PCa care compared to a time and attention control arm.

Detailed description

The investigators will conduct a pilot RCT of STC adapted for PCa with 100 patients randomly assigned to the intervention or control arm in a 1:1 ratio. Primary feasibility outcomes are clinical trial metrics and feasibility, acceptability, and appropriateness of STC. Primary efficacy outcomes are self-efficacy for sexual health communication with providers and rates of sexual health communication with providers. Secondary efficacy outcomes are sexual health outcomes (use of therapies for sexual dysfunction, sexual activity, and sexual satisfaction). Measures of efficacy will be compared between the intervention and control groups.

Interventions

BEHAVIORALStarting the Conversation (STC)

20-minute slideshow, 5-page workbook, 2-page supportive care resource guide focused on sexual health and teaching communication skills to help patients with prostate cancer discuss their sexual health concerns with their healthcare providers.

BEHAVIORALTime and Attention

2-page supportive care resource guide, as well as a 20-minute video slideshow and 5-page pamphlet on diet, sleep, and exercise for patients with prostate cancer.

Sponsors

NYU Langone Health
Lead SponsorOTHER
National Cancer Institute (NCI)
CollaboratorNIH

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adult male with PCa at least 18 years of age * Speak English * Reside in the U.S. * Have internet/web access, and * Report current bother due to sexual dysfunction * Capacity and willingness to provide consent * Have an appointment with a PCa provider at NYU Langone Health during the study accrual period

Exclusion criteria

* Individual with impaired decision-making capacity. * Participation in another part of this study (prior aim)

Design outcomes

Primary

MeasureTime frameDescription
Number of patients who asked a sexual health question during clinic visitPost-Appointment (Day 1)
Self Efficacy - Asking about Sexual HealthBaseline, Post-Appointment (Day 1), Month 2 Follow-UpSelf-efficacy for asking a healthcare provider about sexual health, scored from 0-10. Higher scores indicate greater self-efficacy.
Self Efficacy - Talking about Sexual HealthBaseline, Post-Appointment (Day 1), Month 2 Follow-UpSelf-efficacy for talking about sexual health with a healthcare provider, scored from 0-10. Higher scores indicate greater self-efficacy.
Eligibility rateBaselineProportion of screened individuals who are eligible
Enrollment rateBaselineProportion of eligible individuals who enroll
Retention rateUp to Month 2 Follow-UpProportion of enrolled participants who are not lost to follow-up
Assessment processUp to Month 2 Follow-UpProportion of participants who completed intervention and assessments
Feasibility of Intervention Measure (FIM)Post-Appointment (Day 1)FIM is a validated 4-item scale designed to evaluate whether a specific intervention or practice can be successfully implemented and carried out within a given setting. Each item is rated on a scale from 1-5; the total score is the average of the responses and ranges from 1-5; higher scores indicate greater feasibility.
Acceptability of Intervention Measure (AIM)Post-Appointment (Day 1)AIM is a validated 4-item scale used in implementation research to assess stakeholders' perception that a new program, treatment, or practice is agreeable and satisfactory. Each item is rated on a scale from 1-5; the total score is the average of the responses and ranges from 1-5; a higher overall average indicates a greater level of acceptability for the intervention.
Intervention Appropriateness Measure (IAM)Post-Appointment (Day 1)The Intervention Appropriateness Measure (IAM) is a validated, 4-item tool used in implementation science to assess the perceived fit, relevance, and suitability of an intervention. Each item is rated on scale from 1-5; the total score is the average of responses and ranges from 1-5; higher scores indicate greater appropriateness.
Number of patients who raised a sexual health topic during clinic visitPost-Appointment (Day 1)
Number of patients who discussed sexual health concerns during clinic visitPost-Appointment (Day 1)

Secondary

MeasureTime frameDescription
PROMIS Sexual Function and Satisfaction Measure (PROMIS SexFS v2.0)Baseline, Post-Appointment (Day 1), Month 2 Follow-UpQuestions from the domains of 1) engagement in sexual activity and 2) use of therapeutic aids for sexual activity will be converted into dichotomous variables; proportions will be evaluated at each time point as well as over time using a Z-test for differences in proportions between groups; higher scores indicate greater sexual function and satisfaction. The domain of global satisfaction with sex life will be assessed as the change over time and compared between groups using two-sample t-tests.

Countries

United States

Contacts

CONTACTNatasha Gupta, MD
Natasha.gupta@nyulangone.org646-501-2599
PRINCIPAL_INVESTIGATORNatasha Gupta, MD

NYU Langone Health

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Jul 2, 2026